There was a disappointing drop in price after my first posting. (see link below). Since then there has been very encouraging news on one of its drugs. The good news: Although in small trials, the drug appears to be very helpful in assisting treatment in severe infections with Covid-19. Bad news: multiple law firms are suing CYDY as these opportunistic firms do. Remember: small biotech often quit volatile and risky, i.e. not for everyone. Process your way. Take care. Have a good week.